/PRNewswire/ -- MSD, known as Merck & Co., Inc. in the United States and Canada ,- today announced that SIMPONI ® (golimumab) has received CHMP... ...http://in.advfn.com/p.php?pid=nmona&article=67014255
-- SIMPONI Recommended for Approval in Adult Patients with Severe Active Non-Radiographic Axial Spondyloarthritis LEIDEN, The Netherlands , May... ...http://in.advfn.com/p.php?pid=nmona&article=66981158
/PRNewswire/ --Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the... ...http://in.advfn.com/p.php?pid=nmona&article=66696184
Voluntary, Incentive-based Efforts Will Reduce Greenhouse Gas Emissions, Expand Renewable Energy Production, Help Producers Boost their Operations... ...http://www.pressreleasepoint.com/agriculture-secretary-tom-vilsack-and-senior-white-house-advisor-brian-deese-announce-partnerships-f
GlobeNewswire 2015-04-23 Phase II ARPEGGIO study design to be presented at the 67th American Academy of Neurology (AAN) Annual Meeting, April... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=68115
ICore Software Technologies, offers a...